Limitations of Prostate-specific Antigen Testing After a Prostate Cancer Diagnosis.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 26776937.
- Also identified by DOI 10.1016/j.eururo.2015.12.045.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Prostate-specific antigen (PSA) is frequently used in isolation to guide treatment decisions in men with recurrent prostate cancer, a practice discouraged by prostate cancer working groups and guidelines. Instead, PSA should be used with imaging and other factors to make treatment decisions.
Medical subject headings
- Prostate-Specific Antigen
- Prostatic Neoplasms